Delivery Order SPE2DB22D2009-SPE2DB25FM1JF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency awarded a $1,968.89 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,738.76 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin, with an ultimate completion date of August 28, 2025. This non-competitive delivery order was issued under a firm fixed price arrangement, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a routine pharmaceutical procurement action...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.03 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 unit/mL 3 mL insulin, with an ultimate completion date of August 6, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a single transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $1,301.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin, with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a direct delivery of pharmaceutical products to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and...
- The Defense Logistics Agency awarded a $2,119.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin medication, with a completion date of August 1, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively made with no set-aside designation, and performance will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,316.84 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin, with an ultimate completion date of August 8, 2025. This non-set-aside, competitively awarded contract uses firm fixed price terms and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $1,534.20 delivery order to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The contract, executed on August 6, 2025, with an ultimate completion date of August 7, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $13,711.44 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin, with an ultimate completion date of August 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken,...
- AmerisourceBergen Drug Corp has been awarded a firm fixed-price delivery order valued at $1,278.50 by the Defense Logistics Agency (DLA) for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The award, issued on August 8, 2025, represents a competitive procurement with no set-aside designation and is scheduled for completion by August 11, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1JFDelivery Order
The Defense Logistics Agency awarded a $7,142.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin, with an ultimate completion date of September 8, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order exemplifies AmerisourceBergen's role as a comprehensive pharmaceutical supplier within the federal medical supply chain. The company's IDC with DLA enables it to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract award demonstrates AmerisourceBergen's capability to meet federal procurement standards through competitive solicitation and to handle transactions ranging from modest orders to substantial multi-thousand-dollar commitments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 9/5/25 |